These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 22560996)

  • 1. Detecting chronic solvent encephalopathy in occupations at risk.
    Furu H; Sainio M; Hyvärinen HK; Akila R; Bäck B; Uuksulainen S; Kaukiainen A
    Neurotoxicology; 2012 Aug; 33(4):734-41. PubMed ID: 22560996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A screening programme on chronic solvent-induced encephalopathy among Dutch painters.
    Spee T; van Valen E; van Duivenbooden C; van der Laan G
    Neurotoxicology; 2012 Aug; 33(4):727-33. PubMed ID: 22664100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision rules for assessment of chronic solvent-induced encephalopathy: Results in 2370 patients.
    Verberk MM; van der Hoek JA; van Valen E; Wekking EM; van Hout MS; Hageman G; van der Laan G; van Dijk FJ
    Neurotoxicology; 2012 Aug; 33(4):742-52. PubMed ID: 22722000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic solvent-induced encephalopathy: European consensus of neuropsychological characteristics, assessment, and guidelines for diagnostics.
    van Valen E; van Thriel C; Akila R; Nilson LN; Bast-Pettersen R; Sainio M; van Dijk F; van der Laan G; Verberk M; Wekking E
    Neurotoxicology; 2012 Aug; 33(4):710-26. PubMed ID: 22498091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodal event-related potentials in occupational chronic solvent encephalopathy.
    Keski-Säntti P; Palmu K; Pitkonen M; Liljander S; Partanen JV; Akila R; Sainio M; Holm A
    Neurotoxicology; 2012 Aug; 33(4):703-9. PubMed ID: 22366255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic solvent induced encephalopathy: a step forward.
    van der Laan G; Sainio M
    Neurotoxicology; 2012 Aug; 33(4):897-901. PubMed ID: 22560998
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost of detecting a chronic solvent encephalopathy case by screening.
    Furu H; Sainio M; Ahonen G; Hyvärinen HK; Kaukiainen A
    Neurotoxicology; 2014 Dec; 45():253-9. PubMed ID: 24463353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms of chronic solvent encephalopathy: Euroquest questionnaire study.
    Kaukiainen A; Hyvärinen HK; Akila R; Sainio M
    Neurotoxicology; 2009 Nov; 30(6):1187-94. PubMed ID: 19963103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P300 of auditory event related potentials in occupational chronic solvent encephalopathy.
    Keski-Säntti P; Holm A; Akila R; Tuisku K; Kovala T; Sainio M
    Neurotoxicology; 2007 Nov; 28(6):1230-6. PubMed ID: 17869344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of psychiatric disorders in patients with chronic solvent induced encephalopathy (CSE).
    Visser I; Wekking EM; de Boer AG; de Joode EA; van Hout MS; van Dorsselaer S; Ruhé HG; Huijser J; van der Laan G; van Dijk FJ; Schene AH
    Neurotoxicology; 2011 Dec; 32(6):916-22. PubMed ID: 21609732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of periodical health examinations in detecting occupational chronic solvent encephalopathy.
    Furu HM; Sainio M; Hyvärinen HK; Kaukiainen A
    Occup Environ Med; 2019 Sep; 76(9):688-693. PubMed ID: 31320491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Work ability score of solvent-exposed workers.
    Furu H; Sainio M; Hyvärinen HK; Kaukiainen A
    Int Arch Occup Environ Health; 2018 Jul; 91(5):559-569. PubMed ID: 29594340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EUROQUEST--a questionnaire for solvent related symptoms: factor structure, item analysis and predictive validity.
    Carter N; Iregren A; Söderman E; Olson BA; Karlson B; Lindelöf B; Lundberg I; Osterberg K
    Neurotoxicology; 2002 Dec; 23(6):711-7. PubMed ID: 12520761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom screening in detection of occupational solvent-related encephalopathy.
    Kaukiainen A; Akila R; Martikainen R; Sainio M
    Int Arch Occup Environ Health; 2009 Feb; 82(3):343-55. PubMed ID: 18604551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Euroquest: the validity of a new symptom questionnaire.
    Karlson B; Osterberg K; Orbaek P
    Neurotoxicology; 2000 Oct; 21(5):783-9. PubMed ID: 11130283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative EEG in occupational chronic solvent encephalopathy.
    Keski-Säntti P; Kovala T; Holm A; Hyvärinen HK; Sainio M
    Hum Exp Toxicol; 2008 Apr; 27(4):315-20. PubMed ID: 18684802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobehavioral study on the interactive effects of age and solvent exposure.
    Kiesswetter E; Sietmann B; Zupanic M; Seeber A
    Neurotoxicology; 2000 Oct; 21(5):685-95. PubMed ID: 11130272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupational chronic solvent encephalopathy in Finland 1995-2007: incidence and exposure.
    Keski-Säntti P; Kaukiainen A; Hyvärinen HK; Sainio M
    Int Arch Occup Environ Health; 2010 Aug; 83(6):703-12. PubMed ID: 19941001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological symptoms associated with low-level exposure to solvents and (meth)acrylates among nail technicians.
    LoSasso GL; Rapport LJ; Axelrod BN
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(3):183-9. PubMed ID: 11513102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.